Sanofi obesity drug faces tough EU safety review (Reuters)

Reuters - Sanofi-Aventis SA's obesity pill Acomplia faces a tough review from European drug safety experts this week, with data suggesting officials see issues over the drug's link with suicidal thoughts.

More: continued here

You can respond, or trackback from your own site.